About: Richard Gaynor

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Richard Gaynor Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/c/7nUSNftTNa

Richard B. Gaynor is an American physician specializing in hematology-oncology, educator, drug developer, and business executive. He served as an Associate Professor of Medicine at UCLA School of Medicine (Los Angeles, CA) for nearly a decade, and subsequently as an endowed Professor of Medicine and Microbiology at the University of Texas Southwestern Medical School prior to joining the pharmaceutical industry in 2002. His research on NF-κB, IκB kinase, and other mechanisms regulating viral and cellular gene expression has been covered in leading subject reviews. He has been a top executive at several pharmaceutical companies, with respect to the development and clinical testing of novel anticancer drugs and cell therapies. For over a decade and a half, he worked at Eli Lilly and Company,

Attributes	Values
rdf:type	Thing
rdfs:label	Richard Gaynor (en)
rdfs:comment	Richard B. Gaynor is an American physician specializing in hematology-oncology, educator, drug developer, and business executive. He served as an Associate Professor of Medicine at UCLA School of Medicine (Los Angeles, CA) for nearly a decade, and subsequently as an endowed Professor of Medicine and Microbiology at the University of Texas Southwestern Medical School prior to joining the pharmaceutical industry in 2002. His research on NF-κB, IκB kinase, and other mechanisms regulating viral and cellular gene expression has been covered in leading subject reviews. He has been a top executive at several pharmaceutical companies, with respect to the development and clinical testing of novel anticancer drugs and cell therapies. For over a decade and a half, he worked at Eli Lilly and Company, (en)
dcterms:subject	University of Texas Southwestern Medical Center faculty Living people Year of birth missing (living people) American oncologists Cancer researchers Texas Tech University alumni University of California, Los Angeles faculty Eli Lilly and Company people BioNTech University of Texas Southwestern Medical Center alumni
Wikipage page ID	70215272 (xsd:integer)
Wikipage revision ID	1096976777 (xsd:integer)
Link from a Wikipage to another Wikipage	Cambridge, Massachusetts American Society for Clinical Investigation BioNTech David Geffen School of Medicine at UCLA University of Texas Southwestern Medical Center faculty Pemetrexed Research and development University of Texas Southwestern Medical Center Veterans Health Administration IκB kinase Living people Year of birth missing (living people) Eli Lilly and Company dbr:Gemcitabine NF-κB Professor TAF1 American oncologists Cancer researchers Texas Tech University alumni University of California, Los Angeles faculty Cetuximab William P. Clements Jr. University Hospital MNAT1 Abemaciclib American Association for Cancer Research Damon Runyon Cancer Research Foundation Drug development Nonprofit organization PMC (identifier) PMID (identifier) Parkland Memorial Hospital Cell therapy Texas Tech University Stand Up to Cancer Chemotherapy Eli Lilly and Company people BioNTech Doi (identifier) Association of American Physicians University of Texas Southwestern Medical Center alumni Business executive Financial endowment ISSN (identifier) Ramucirumab TARBP1
sameAs	Richard Gaynor Richard Gaynor
dbp:wikiPageUsesTemplate	dbt:Authority_control dbt:Reflist dbt:Short_description
has abstract	Richard B. Gaynor is an American physician specializing in hematology-oncology, educator, drug developer, and business executive. He served as an Associate Professor of Medicine at UCLA School of Medicine (Los Angeles, CA) for nearly a decade, and subsequently as an endowed Professor of Medicine and Microbiology at the University of Texas Southwestern Medical School prior to joining the pharmaceutical industry in 2002. His research on NF-κB, IκB kinase, and other mechanisms regulating viral and cellular gene expression has been covered in leading subject reviews. He has been a top executive at several pharmaceutical companies, with respect to the development and clinical testing of novel anticancer drugs and cell therapies. For over a decade and a half, he worked at Eli Lilly and Company, where he became the Senior Vice President of Oncology Clinical Development and Medical Affairs in 2013. Gaynor was President of R&D at Neon Therapeutics from 2016 to 2020, when he became the President of BioNTech US, both pharmaceutical companies headquartered in Cambridge, MA. His honors include being elected a member of the American Society for Clinical Investigation, and the Association of American Physicians. (en)
prov:wasDerivedFrom	wikipedia-en:Richard_Gaynor?oldid=1096976777&ns=0
page length (characters) of wiki page	17971 (xsd:nonNegativeInteger)
foaf:isPrimaryTopicOf	wikipedia-en:Richard_Gaynor
is Link from a Wikipage to another Wikipage of	University of Texas Southwestern Medical Center Levi Garraway Richard B. Gaynor
is Wikipage redirect of	Richard B. Gaynor
is foaf:primaryTopic of	wikipedia-en:Richard_Gaynor

Faceted Search & Find service v1.17_git147 as of Sep 06 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3332 as of Dec 5 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 69 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software